Home » Reports » Broker Ratings » AstraZeneca plc 26.2% Potential Upside Indicated by Barclays Capital
broker ratings

AstraZeneca plc 26.2% Potential Upside Indicated by Barclays Capital

AstraZeneca plc using EPIC/TICKER code (LON:AZN) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘TOP PICK’ this morning by analysts at Barclays Capital. AstraZeneca plc are listed in the Health Care sector within UK Main Market. Barclays Capital have set their target price at 6300 GBX on its stock. This now indicates the analyst believes there is a possible upside of 26.2% from today’s opening price of 4992 GBX. Over the last 30 and 90 trading days the company share price has decreased 161 points and decreased 153 points respectively. The 52 week high for the share price is currently at 5520 GBX while the year low share price is currently 4260 GBX.

AstraZeneca plc has a 50 day moving average of 5,015.89 GBX and the 200 Day Moving Average price is recorded at 5,011.71. There are currently 1,266,221,604 shares in issue with the average daily volume traded being 1,655,702. Market capitalisation for LON:AZN is £62,874,233,747 GBP.

You might also find these articles of interest:

Register here to be notified of future articles like this
Get all our broker ratings on Twitter as they are published!